Discover
IGMS
IGM Biosciences, Inc.
1.27
undefined x undefined
undefined x undefined
bid
ask
+
0.00
0.00%
04:00 PM
| Ytd | -79.21% | |
| 1y | -85.70% |
1.27
day range
1.27
6.15
52 week range
22.50
| Open | 1.30 | Prev Close | 1.27 | Low | 1.27 | High | 1.27 | Mkt Cap | 387.11M |
| Vol | 1.59M | Avg Vol | 268.09K | EPS | -3.61 | P/E | N/A | Forward P/E | -2.71 |
| Beta | 0.19 | Short Ratio | 11.22 | Inst. Own | 63.97% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 12.15 | 200-d Avg | 10.57 | 1yr Est | 19.73 |
| Income Statement | |||
| Total Revenue | 143.62M | ||
| Revenues (USD) | 143.62M | ||
| Gross Profit | 143.62M | ||
| Operating Expenses | 47.36M | ||
| Research and Development Expense | 5.86M | ||
| Selling, General and Administrative Expense | 9.58M | ||
| Operating Income | 96.26M | ||
| Net Income | 97.58M | ||
| Net Income Common Stock | 97.58M | ||
| Net Income Common Stock (USD) | 97.58M | ||
| Consolidated Income | 97.58M | ||
| Earnings per Basic Share | 1.59 | ||
| Earnings per Basic Share (USD) | 1.59 | ||
| Earnings per Diluted Share | 1.58 | ||
| Earning Before Interest & Taxes (EBIT) | 97.58M | ||
| Earning Before Interest & Taxes (USD) | 97.58M | ||
| Weighted Average Shares | 61.46M | ||
| Weighted Average Shares Diluted | 61.75M | ||
| Balance Sheet | |||
| Cash and Equivalents | 30.65M | ||
| Cash and Equivalents (USD) | 30.65M | ||
| Investments | 73.66M | ||
| Investments Current | 73.66M | ||
| Current Assets | 106.99M | ||
| Total Assets | 106.99M | ||
| Current Liabilities | 6.06M | ||
| Total Liabilities | 6.06M | ||
| Accumulated Retained Earnings (Deficit) | -972.34M | ||
| Accumulated Other Comprehensive Income | 8.00K | ||
| Shareholders Equity | 100.93M | ||
| Shareholders Equity (USD) | 100.93M | ||
| Trade and Non-Trade Payables | 2.40M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 938.00K | ||
| Net Cash Flow from Financing | 12.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -6.23M | ||
| Capital Expenditure | 2.37M | ||
| Issuance (Purchase) of Equity Shares | 12.00K | ||
| Net Cash Flow from Investing | 44.54M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 42.17M | ||
| Net Cash Flow from Operations | -50.79M | ||
| Share Based Compensation | 2.71M | ||